{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:44:43Z","timestamp":1790628283502,"version":"4.1.0"},"reference-count":232,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003970","name":"Isfahan University of Medical Sciences","doi-asserted-by":"publisher","award":["1398.628"],"award-info":[{"award-number":["1398.628"]}],"id":[{"id":"10.13039\/501100003970","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003970","name":"Isfahan University of Medical Sciences","doi-asserted-by":"publisher","award":["398795"],"award-info":[{"award-number":["398795"]}],"id":[{"id":"10.13039\/501100003970","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","ajog.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.ajog.2024.10.004","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T06:20:57Z","timestamp":1728541257000},"page":"164-187.e31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["New insights into the relationship of antim\u00fcllerian hormone with polycystic ovary syndrome and its diagnostic accuracy: an updated and extended meta-analysis using a marginal beta-binomial model"],"prefix":"10.1016","volume":"232","author":[{"given":"Mostafa","family":"Barghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7825-2388","authenticated-orcid":false,"given":"Zahra","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahimeh","family":"Haghighatdoost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awat","family":"Feizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahin","family":"Hashemipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2024.10.004_bib1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","article-title":"Polycystic ovary syndrome","volume":"370","author":"Norman","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2024.10.004_bib2","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2024.10.004_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede","year":"2010","journal-title":"BMC Med"},{"key":"10.1016\/j.ajog.2024.10.004_bib4","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4103\/0378-6323.110759","article-title":"Polycystic ovarian syndrome","volume":"79","author":"Madnani","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.ajog.2024.10.004_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2024.10.004_bib6","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/humupd\/dmw025","article-title":"The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance","volume":"22","author":"Balen","year":"2016","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2024.10.004_bib7","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1093\/humrep\/deu242","article-title":"Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles","volume":"29","author":"Dewailly","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2024.10.004_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00006254-198202000-00001","article-title":"Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called \u201chyperthecosis\u201d","volume":"37","author":"Hughesdon","year":"1982","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.ajog.2024.10.004_bib9","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0140-6736(03)14410-8","article-title":"Formation and early development of follicles in the polycystic ovary","volume":"362","author":"Webber","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2024.10.004_bib10","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1210\/jc.2004-0643","article-title":"Stockpiling of transitional and classic primary follicles in ovaries of women with polycystic ovary syndrome","volume":"89","author":"Maciel","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2024.10.004_bib11","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1210\/jc.2003-030932","article-title":"Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age","volume":"89","author":"Laven","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2024.10.004_bib12","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1210\/jc.2003-030727","article-title":"Elevated serum level of anti-Mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest","volume":"88","author":"Pigny","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2024.10.004_bib13","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3389\/fendo.2020.00641","article-title":"Role of anti-M\u00fcllerian hormone in the pathogenesis of polycystic ovary syndrome","volume":"11","author":"Dewailly","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ajog.2024.10.004_bib14","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.4158\/EP-2019-0098","article-title":"Diagnostic value of anti-M\u00fcllerian hormone as a biomarker for polycystic ovary syndrome: a meta-analysis update","volume":"25","author":"Zhao","year":"2019","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ajog.2024.10.004_bib15","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1093\/ejendo\/lvad096","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"189","author":"Teede","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ajog.2024.10.004_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10055","article-title":"Novel role for anti-M\u00fcllerian hormone in the regulation of GnRH neuron excitability and hormone secretion","volume":"7","author":"Cimino","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajog.2024.10.004_bib17","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/REP-19-0197","article-title":"Mechanisms of intergenerational transmission of polycystic ovary syndrome","volume":"159","author":"Dumesic","year":"2020","journal-title":"Reproduction"},{"key":"10.1016\/j.ajog.2024.10.004_bib18","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1111\/jog.15233","article-title":"Updated meta-analysis on the diagnostic accuracy of serum anti-Mullerian hormone in poly cystic ovary syndrome involving 13 509 subjects","volume":"48","author":"Anand","year":"2022","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.ajog.2024.10.004_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.ajog.2024.10.004_bib20","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajog.2024.10.004_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/sim.6620","article-title":"Meta-analysis of studies with bivariate binary outcomes: a marginal beta-binomial model approach","volume":"35","author":"Chen","year":"2016","journal-title":"Stat Med"},{"key":"10.1016\/j.ajog.2024.10.004_bib23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2024.10.004_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.719029","article-title":"Variation in the measurement of anti-M\u00fcllerian hormone \u2013 what are the laboratory issues?","volume":"12","author":"Punchoo","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ajog.2024.10.004_bib25","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1136\/bmj.320.7249.1574","article-title":"Empirical assessment of effect of publication bias on meta-analyses","volume":"320","author":"Sutton","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2024.10.004_bib26","series-title":"Systematic reviews in health care: meta-analysis in context","author":"Egger","year":"2008"},{"key":"10.1016\/j.ajog.2024.10.004_bib27","first-page":"167","article-title":"Hyperhomocysteinemia and pregnancy outcomes in women with polycystic ovary syndrome: a case-control study","volume":"21","author":"Asanidze","year":"2023","journal-title":"Int J Reprod Biomed"},{"key":"10.1016\/j.ajog.2024.10.004_bib28","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2147\/IJWH.S403347","article-title":"Diagnostic performance of anti-M\u00fcllerian hormone, luteinizing hormone to follicle-stimulating hormone ratio, testosterone, and prolactin to predict polycystic ovary syndrome among Sudanese women","volume":"15","author":"Alhassan","year":"2023","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.ajog.2024.10.004_bib29","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1007\/s43032-023-01195-y","article-title":"Serum anti-M\u00fcllerian hormone (AMH) levels among different PCOS phenotypes and its correlation with clinical, endocrine, and metabolic markers of PCOS","volume":"30","author":"Malhotra","year":"2023","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ajog.2024.10.004_bib30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.5603\/GP.a2021.0239","article-title":"Is there association between thyroid stimulating hormone levels and the four phenotypes in polycystic ovary syndrome?","volume":"94","author":"Lee","year":"2023","journal-title":"Ginekol Pol"},{"key":"10.1016\/j.ajog.2024.10.004_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12958-023-01064-y","article-title":"The reference value of anti\u2013M\u00fcllerian hormone to diagnose polycystic ovary syndrome is inversely associated with BMI: a retrospective study","volume":"21","author":"Zhang","year":"2023","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.ajog.2024.10.004_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1104550","article-title":"Granulosa cell-derived miR-379- 5p regulates macrophage polarization in polycystic ovarian syndrome","volume":"14","author":"Salehi","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajog.2024.10.004_bib33","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12920-023-01541-8","article-title":"Vitamin D receptor gene polymorphism and polycystic ovary syndrome susceptibility","volume":"16","author":"Albahlol","year":"2023","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.ajog.2024.10.004_bib34","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1080\/03007995.2023.2204768","article-title":"Determining the age group-based cut-off values of serum anti-Mullerian hormone concentrations to diagnose polycystic ovary syndrome","volume":"39","author":"Timur","year":"2023","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ajog.2024.10.004_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104535","article-title":"Articles Hypothalamic neuroglial plasticity is regulated by anti- M\u00fcllerian hormone and disrupted in polycystic ovary syndrome","volume":"90","author":"Barbotin","year":"2023","journal-title":"EBiomedicine"},{"key":"10.1016\/j.ajog.2024.10.004_bib36","doi-asserted-by":"crossref","first-page":"329","DOI":"10.51253\/pafmj.v73i2.4249","article-title":"Diagnostic accuracy of anti-Mullerian hormone for polycystic ovary syndrome","volume":"73","author":"Bahadur","year":"2023","journal-title":"Pak Armed Forces Med"},{"key":"10.1016\/j.ajog.2024.10.004_bib37","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s12291-022-01058-4","article-title":"Evaluation of the Efficacy and Threshold of Serum anti- M\u00fcllerian hormone (AMH) Levels for Diagnosis and Prediction of polycystic ovary syndrome (PCOS) among Indian Women","volume":"38","author":"Sumji","year":"2023","journal-title":"Indian J Clin Biochem"},{"key":"10.1016\/j.ajog.2024.10.004_bib38","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00404-022-06874-w","article-title":"The diagnostic performance of antiMullerian hormone for polycystic ovarian syndrome and polycystic ovarian morphology","volume":"307","author":"Vural","year":"2023","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2024.10.004_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1117761","article-title":"High density lipoprotein- associated proteins in non-obese women with and without polycystic ovary syndrome","volume":"14","author":"Butler","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ajog.2024.10.004_bib40","doi-asserted-by":"crossref","DOI":"10.1080\/09513590.2023.2206927","article-title":"Diagnostic value of anti-M\u00fcllerian hormone combined with androgen-levels in Chinese patients with polycystic ovary syndrome","volume":"39","author":"Jiang","year":"2023","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2024.10.004_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.915245","article-title":"Application of a new ultrasound criterion for the diagnosis of polycystic ovary syndrome","volume":"13","author":"Gim\u00e9nez-Peralta","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ajog.2024.10.004_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1000261","article-title":"The relationship between the level of vitamin D, leptin and FGF23 in girls and young women with polycystic ovary syndrome","volume":"13","author":"Bia\u0142ka-Kosiec","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ajog.2024.10.004_bib43","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/14647273.2020.1795574","article-title":"Anogenital distance and anti-M\u00fcllerian hormone combined improves the diagnosis of polycystic ovary syndrome","volume":"25","author":"Prieto-S\u00e1nchez","year":"2022","journal-title":"Hum Fertil (Camb)"},{"key":"10.1016\/j.ajog.2024.10.004_bib44","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7238344","article-title":"The relationship between ovarian ultrasound parameters and endocrine and metabolic indicators in patients with ovarian syndrome","volume":"2022","author":"Sheng","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.ajog.2024.10.004_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.845165","article-title":"Elevated serum leptin levels as a predictive marker for polycystic ovary syndrome","volume":"13","author":"Peng","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ajog.2024.10.004_bib46","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2147\/IJWH.S329082","article-title":"A\u00a0cross-sectional study on potential ovarian volume and related factors in women with polycystic ovary syndrome from infertile couples","volume":"13","author":"Le","year":"2021","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.ajog.2024.10.004_bib47","article-title":"Abnormal activation of tryptophan- kynurenine pathway in women with polycystic ovary syndrome","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ajog.2024.10.004_bib48","first-page":"6163","article-title":"Vitamin D deficiency and metabolic syndrome in polycystic ovarian disorder (Pcod) patients along with anti-M\u00fcllerian hormone levels","volume":"13","author":"Bansal","year":"2022","journal-title":"J\u00a0Pharm Negat Results"},{"key":"10.1016\/j.ajog.2024.10.004_bib49","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/09513590.2021.2016694","article-title":"Is anti-M\u00fcllerian hormone a useful biomarker in the diagnosis of polycystic ovary syndrome in Chinese adolescents? Is anti-M\u00fcllerian hormone a useful biomarker in the diagnosis of polycystic ovary","volume":"38","author":"Li","year":"2022","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2024.10.004_bib50","first-page":"6015","article-title":"Tumor necrosis factor alpha level in the uterine fluid of patients with polycystic ovary syndrome and its correlation with clinical parameters","volume":"15","author":"Ha","year":"2022","journal-title":"J\u00a0Inflam Res"},{"key":"10.1016\/j.ajog.2024.10.004_bib51","first-page":"118","article-title":"Insulin \u2013 like peptide 5 (INSL5) positively correlates with anti - M\u00fcllerian hormone (AMH) in women with the polycystic ovary syndrome: a case \u2013 control study","volume":"15","author":"Chen","year":"2022","journal-title":"J\u00a0Ovarian Res"},{"key":"10.1016\/j.ajog.2024.10.004_bib52","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12020-020-02538-4","article-title":"Variation analysis of anti-M\u00fcllerian hormone gene in Chinese women with polycystic ovary syndrome","volume":"72","author":"Qin","year":"2021","journal-title":"Endocrine"},{"key":"10.1016\/j.ajog.2024.10.004_bib53","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.2147\/DMSO.S299558","article-title":"The relationship of anti-Mullerian hormone in polycystic ovary syndrome patients with different subgroups","volume":"14","author":"Ran","year":"2021","journal-title":"Diabetes Metab Syndr Obes Published online"},{"key":"10.1016\/j.ajog.2024.10.004_bib54","doi-asserted-by":"crossref","first-page":"e1084","DOI":"10.1210\/clinem\/dgaa949","article-title":"Anti-M\u00fcllerian hormone levels in adolescence in relation to long-term follow-up for presence of polycystic ovary syndrome","volume":"106","author":"Caanen","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2024.10.004_bib55","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.3390\/nu13124217","article-title":"Body composition and its impact on the hormonal disturbances in women with polycystic ovary syndrome","volume":"13","author":"Bizo\u0144","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.ajog.2024.10.004_bib56","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/09513590.2020.1825670","article-title":"Serum kisspeptin levels correlated with anti- Mullerian hormone levels in women with and without polycystic ovarian syndrome","volume":"37","author":"Mut","year":"2021","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2024.10.004_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23861","article-title":"Age-group-specific reference intervals for anti-M\u00fcllerian hormone and its diagnostic performance for polycystic ovary syndrome in a Korean population","volume":"35","author":"Song","year":"2021","journal-title":"J\u00a0Clin Lab Anal"},{"key":"10.1016\/j.ajog.2024.10.004_bib58","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.rbmo.2021.01.012","article-title":"Anti-M\u00fcllerian hormone as a driving force of polycystic ovary syndrome, independently from insulin resistance","volume":"42","author":"Robin","year":"2021","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ajog.2024.10.004_bib59","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12958-021-00755-8","article-title":"Age-specific cut-off levels of anti-M\u00fcllerian hormone can be used as diagnostic markers for polycystic ovary syndrome","volume":"19","author":"Tehrani","year":"2021","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.ajog.2024.10.004_bib60","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20211658","article-title":"Effects of serum irisin, neuregulin 4, and weight management on obese adolescent girls with polycystic ovary syndrome","volume":"41","author":"Cao","year":"2021","journal-title":"Biosci Rep"},{"key":"10.1016\/j.ajog.2024.10.004_bib61","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1055\/a-1499-7718","article-title":"Anti-M\u00fcllerian hormone accelerates pathological process of insulin resistance in polycystic ovary syndrome patients","volume":"53","author":"Li","year":"2021","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.ajog.2024.10.004_bib62","first-page":"2101","article-title":"The effect of ageing on clinical, hormonal and sonographic features associated with PCOS-a long-term follow-up study","volume":"10","author":"Jacewicz-\u015awi\u0119cka","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.ajog.2024.10.004_bib63","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/19396368.2020.1860155","article-title":"Correlation between anti-M\u00fcllerian hormone levels and antral follicle counts in polycystic ovary and metabolic syndromes","volume":"67","author":"Fu","year":"2021","journal-title":"Syst Biol Reprod Med"},{"key":"10.1016\/j.ajog.2024.10.004_bib64","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.fertnstert.2020.07.023","article-title":"A\u00a0patient-specific model combining antiM\u00fcllerian hormone and body mass index as a predictor of polycystic ovary syndrome and other oligo-anovulation disorders","volume":"115","author":"Vagios","year":"2021","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2024.10.004_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.659717","article-title":"Serum anti-M\u00fcllerian hormone levels were negatively associated with body fat percentage in PCOS patients","volume":"12","author":"Luo","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ajog.2024.10.004_bib66","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/09513590.2021.1943344","article-title":"Challenges in diagnosis of polycystic ovary syndrome in adolescence","volume":"37","author":"Asanidze","year":"2021","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2024.10.004_bib67","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/ijgo.13515","article-title":"Age-related diagnostic threshold of anti-M\u00fcllerian hormone for polycystic ovarian syndrome","volume":"153","author":"Kakkad","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2024.10.004_bib68","doi-asserted-by":"crossref","first-page":"57","DOI":"10.14715\/cmb\/2021.67.5.8","article-title":"Expression of serum PSA, Nesfatin-1, and AMH in patients with polycystic ovary syndrome","volume":"67","author":"Wang","year":"2022","journal-title":"Cell Mol Biol"},{"key":"10.1016\/j.ajog.2024.10.004_bib69","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3233\/THC-218002","article-title":"DNA methylation of AMHRII and INSR gene is associated with the pathogenesis of polycystic ovary syndrome (PCOS)","volume":"29","author":"Zhong","year":"2021","journal-title":"Technol Heal Care"},{"key":"10.1016\/j.ajog.2024.10.004_bib70","first-page":"97","article-title":"Decreased SFRP5 correlated with excessive metabolic inflammation in polycystic ovary syndrome could be reversed by metformin: implication of its role in dysregulated metabolism","volume":"14","author":"Zhang","year":"2021","journal-title":"J\u00a0Ovarian Res"},{"key":"10.1016\/j.ajog.2024.10.004_bib71","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1139\/cjpp-2019-0413","article-title":"Gut microbiota dysbiosis in polycystic ovary syndrome: association with obesity\u2014a preliminary report","volume":"98","author":"Liang","year":"2020","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.ajog.2024.10.004_bib72","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.fertnstert.2019.12.012","article-title":"Adjusting anti-M \u20ac ullerian hormone levels for age and body mass index improves detection of polycystic ovary syndrome","volume":"113","author":"Palomaki","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2024.10.004_bib73","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.omtn.2020.11.005","article-title":"Aberrant elevation of GDF8 impairs granulosa-lutein cell glucose metabolism via upregulating SERPINE1 expression in patients with PCOS","volume":"23","author":"Bai","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.ajog.2024.10.004_bib74","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s10815-020-01865-9","article-title":"The impact of polycystic ovary syndrome and body mass index on the absorption of recombinant human follicle stimulating hormone","volume":"37","author":"Lee","year":"2020","journal-title":"J\u00a0Assist Reprod Genet"},{"key":"10.1016\/j.ajog.2024.10.004_bib75","doi-asserted-by":"crossref","first-page":"661","DOI":"10.5603\/GP.a2020.0122","article-title":"Comparison of anti-M\u00fcllerian hormone (AMH) and hormonal assays for phenotypic classification of polycystic ovary syndrome","volume":"91","author":"Ozay","year":"2020","journal-title":"Ginekol Pol"},{"key":"10.1016\/j.ajog.2024.10.004_bib76","first-page":"600","article-title":"Assessment of anti-M\u00fcllerian hormone and anti ovarian antibody in the sera of patients with polycystic ovarian syndrome in AL-Najaf Al-Ashraf province","volume":"20","author":"Al-naffakh","year":"2020","journal-title":"Medico-Legal Updat"},{"key":"10.1016\/j.ajog.2024.10.004_bib77","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.rbmo.2020.07.020","article-title":"The proportion of cleaved anti-M\u00fcllerian hormone is higher in serum but not follicular fluid of obese women independently of polycystic ovary syndrome","volume":"41","author":"Peign\u00e9","year":"2020","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ajog.2024.10.004_bib78","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.18203\/2320-1770.ijrcog20203847","article-title":"Role of anti-Mullerian hormone as a diagnostic tool for polycystic ovary syndrome","volume":"9","author":"Singh","year":"2020","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.10.004_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.144560","article-title":"Association of estrogen receptor gene variants (ESR1 and ESR2) with polycystic ovary syndrome in Tunisia","volume":"741","author":"Douma","year":"2020","journal-title":"Gene"},{"key":"10.1016\/j.ajog.2024.10.004_bib80","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12958-020-00676-y","article-title":"The association between anti-M\u00fcllerian hormone and vitamin 25(OH) D serum levels and polycystic ovarian syndrome in adolescent females","volume":"18","author":"Simpson","year":"2020","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.ajog.2024.10.004_bib81","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12902-020-00569-6","article-title":"Role of anti-M\u00fcllerian hormone and testosterone in follicular growth: a cross-sectional study","volume":"20","author":"Lv","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.ajog.2024.10.004_bib82","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1515\/cclm-2019-1059","article-title":"Age-specific reference values improve the diagnostic performance of AMH in polycystic ovary syndrome","volume":"58","author":"Evliyaoglu","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ajog.2024.10.004_bib83","first-page":"440","article-title":"Ovarian reserve and serum concentration of thyroid peroxidase antibodies in euthyroid women with different polycystic ovary syndrome phenotypes","volume":"11","author":"Adamska","year":"2020","journal-title":"Front Cell Infect Microbiol (Lausanne)"},{"key":"10.1016\/j.ajog.2024.10.004_bib84","first-page":"27","article-title":"Relationship between serum levels of anti-M\u00fcllerian hormone, adiponectin and oxidative stress markers in patients with polycystic ovary syndrome","volume":"14","author":"Kohzadi","year":"2020","journal-title":"Int J Fertil Steril"},{"key":"10.1016\/j.ajog.2024.10.004_bib85","first-page":"1","article-title":"Anti-M\u00fcllerian Hormone (AMH) new cutoff as a possible tool for the diagnosis of polycystic ovary syndrome (PCOS)","volume":"3","author":"Alnawaiseh","year":"2020","journal-title":"J\u00a0Biomed Sci Res"},{"key":"10.1016\/j.ajog.2024.10.004_bib86","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1093\/humrep\/deaa199","article-title":"Loss of anti-M\u00fcllerian hormone (AMH) immunoactivity due to a homozygous AMH gene variant rs10417628 in a woman with classical polycystic ovary syndrome (PCOS)","volume":"35","author":"Hoyos","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2024.10.004_bib87","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.repbio.2020.04.006","article-title":"Polycystic ovary syndrome and endothelial dysfunction: a potential role for soluble lectin-like oxidized low density lipoprotein receptor-1","volume":"20","author":"Oncul","year":"2020","journal-title":"Reprod Biol"},{"key":"10.1016\/j.ajog.2024.10.004_bib88","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/humrep\/deaa098","article-title":"Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome","volume":"35","author":"Henr\u00edquez","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2024.10.004_bib89","doi-asserted-by":"crossref","first-page":"8993","DOI":"10.1038\/s41598-020-65890-5","article-title":"Role of androgen receptor for reconsidering the \u201d true \u201d polycystic ovarian morphology in PCOS","volume":"10","author":"Gao","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajog.2024.10.004_bib90","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/1471-0528.16147","article-title":"Age-specific reference ranges of serum anti-M\u00fcllerian hormone in healthy women and its application in diagnosis of polycystic ovary syndrome: a population study","volume":"127","author":"Li","year":"2020","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2024.10.004_bib91","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13974","article-title":"A\u00a0prospective study of anti-Mullerian hormone and other ovarian and adrenal hormones in adult female acne","volume":"33","author":"Bansal","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ajog.2024.10.004_bib92","first-page":"1831","article-title":"The relevant hormonal levels and diagnostic features of polycystic ovary syndrome in adolescents","volume":"9","author":"Khashchenko","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.ajog.2024.10.004_bib93","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/labmed\/lmy068","article-title":"Advantages of serum anti-M\u00fcllerian hormone as a marker for polycystic ovarian syndrome","volume":"50","author":"Shi","year":"2019","journal-title":"Lab Med"},{"key":"10.1016\/j.ajog.2024.10.004_bib94","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/biolre\/ioy187","article-title":"Effects of letrozole and clomiphene citrate on Wnt signaling pathway in endometrium of polycystic ovarian syndrome and healthy women","volume":"100","author":"Mehdinejadiani","year":"2019","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ajog.2024.10.004_bib95","first-page":"2467","article-title":"The regulation and signalling of anti-M\u00fcllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome","volume":"7","author":"Dilaver","year":"2019","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2024.10.004_bib96","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1507\/endocrj.EJ19-0004","article-title":"Long non-coding RNA H19 is associated with polycystic ovary syndrome in Chinese women: a preliminary study","volume":"66","author":"Qin","year":"2019","journal-title":"Endocr J"},{"key":"10.1016\/j.ajog.2024.10.004_bib97","first-page":"175","article-title":"Anti-M\u00fcllerian hormone as a surrogate marker for hormonal dysfunction and sonographic pattern in polycystic ovarian syndrome","volume":"11","author":"Gupta","year":"2019","journal-title":"J\u00a0S Asian Fed Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.10.004_bib98","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3390\/diagnostics9040136","article-title":"Serum anti-M\u00fcllerian hormone in the diagnosis of polycystic ovary syndrome in association with clinical symptoms","volume":"9","author":"Ahmed","year":"2019","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.ajog.2024.10.004_bib99","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1080\/09513590.2019.1616689","article-title":"The value of anti-Mullerian hormone in the management of polycystic ovary syndrome in adolescents","volume":"35","author":"Asanidze","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2024.10.004_bib100","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.fertnstert.2019.05.021","article-title":"Changes in diet composition with urbanization and its effect on the polycystic ovarian syndrome phenotype in a western Indian population","volume":"112","author":"Kulkarni","year":"2019","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2024.10.004_bib101","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/cen.13934","article-title":"Exploration of the role of anti-Mullerian hormone and LH\/FSH ratio in diagnosis of polycystic ovary syndrome","volume":"90","author":"Le","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ajog.2024.10.004_bib102","first-page":"104","article-title":"Establishing an anti-M\u00fcllerian hormone cutoff for diagnosis of polycystic ovarian syndrome in women of reproductive age-bearing Indian ethnicity using the automated anti-M\u00fcllerian hormone assay","volume":"12","author":"Mahajan","year":"2019","journal-title":"J\u00a0Hum Reprod Sci"},{"key":"10.1016\/j.ajog.2024.10.004_bib103","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1080\/01443615.2019.1587604","article-title":"AMH in combination with SHBG for the diagnosis of polycystic ovary syndrome","volume":"39","author":"Calzada","year":"2019","journal-title":"J\u00a0Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2024.10.004_bib104","first-page":"595","article-title":"A\u00a0medical bioscience study of serum levels of paraoxonase 1 activity and total antioxidant capacity relationship with anti-M\u00fcllerian hormone in polycystic ovary syndrome","volume":"599","author":"Jabbar","year":"2019","journal-title":"Eurasian J Biosci"},{"key":"10.1016\/j.ajog.2024.10.004_bib105","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.rbmo.2019.08.007","article-title":"Investigation of soluble anti-M\u00fcllerian hormone receptor type 2 as a biomarker for diagnosis of female fertility disorders","volume":"39","author":"Olivier","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ajog.2024.10.004_bib106","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1055\/a-0871-6831","article-title":"Is there a relationship between vitamin D deficiency status and PCOS in infertile women? Gibt es eine Beziehung zwischen vitamin-D-Mangel und PCOS bei unfruchtbaren Frauen?","volume":"79","author":"Arslan","year":"2019","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1016\/j.ajog.2024.10.004_bib107","first-page":"84","article-title":"Relation between anti-M\u00fcllerian hormone with antral follicle count and ovarian volume in polycystic ovary syndrome","volume":"52","author":"Youssef","year":"2019","journal-title":"Arab J Nucl Sci Appl"},{"key":"10.1016\/j.ajog.2024.10.004_bib108","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/09513590.2018.1559807","article-title":"Hormone profiling, including anti-M\u00fcllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes","volume":"35","author":"Sova","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2024.10.004_bib109","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1111\/jog.14097","article-title":"Defining polycystic ovary syndrome phenotype in Vietnamese women","volume":"45","author":"Cao","year":"2019","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.ajog.2024.10.004_bib110","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1080\/01443615.2019.1581754","article-title":"Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome","volume":"39","author":"Eken","year":"2019","journal-title":"J\u00a0Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2024.10.004_bib111","first-page":"32","article-title":"The relation between serum anti-M\u00fcllerian hormone levels and follicle count in polycystic ovary syndrome","volume":"4","author":"Okcu","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ajog.2024.10.004_bib112","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.tjog.2018.06.015","article-title":"Assessment of oxytocin level, glucose metabolism components and cutoff values for oxytocin and anti-Mullerian hormone in infertile PCOS women","volume":"57","author":"Jahromi","year":"2018","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.10.004_bib113","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/cen.13755","article-title":"Simplified 4-item criteria for polycystic ovary syndrome: a bridge too far?","volume":"89","author":"Indran","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ajog.2024.10.004_bib114","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.3889\/oamjms.2018.260","article-title":"Assessment of the role of the anti-Mullerian hormone, luteinizing hormone\/follicle stimulating hormone ratio in the diagnosis of polycystic ovary syndrome in Sudanese women","volume":"6","author":"Tola","year":"2018","journal-title":"Open Access Maced J Med Sci"},{"key":"10.1016\/j.ajog.2024.10.004_bib115","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.tjog.2018.06.004","article-title":"Accuracy of anti-M\u00fcllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women","volume":"57","author":"Wongwananuruk","year":"2018","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.10.004_bib116","article-title":"Correlation of anti-M\u00fcllerian hormone with clinical, hormonal and ultrasonographic parameters in PCOS and normo-ovulatory women: an experience of single tertiary care center","volume":"30","author":"Agrawal","year":"2018","journal-title":"Ital J Gynecol Obstet"},{"key":"10.1016\/j.ajog.2024.10.004_bib117","first-page":"448","article-title":"Anti-M\u00fcllerian hormone as a diagnostic marker in Egyptian Infertile polycystic ovary syndrome females: correlations with vitamin D, total testosterone, dyslipidemia and anthropometric parameters","volume":"37","author":"Bakeer","year":"2018","journal-title":"J\u00a0Med Biochem"},{"key":"10.1016\/j.ajog.2024.10.004_bib118","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1080\/09513590.2018.1459548","article-title":"Downregulation of serum long noncoding RNA GAS5 may contribute to insulin resistance in PCOS patients","volume":"34","author":"Lin","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2024.10.004_bib119","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13224-017-1066-4","article-title":"Role of AMH as diagnostic tool for polycystic ovarian syndrome","volume":"68","author":"Saxena","year":"2018","journal-title":"J\u00a0Obstet Gynaecol India"},{"key":"10.1016\/j.ajog.2024.10.004_bib120","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.15537\/smj.2018.10.23413","article-title":"Can we use serum anti-Mullerian hormone to differentiate the diagnosis between polycystic ovary syndrome patients and healthy women with polycystic ovarian morphology and regular menstrual cycles","volume":"39","author":"Aydo\u011fmu\u015f","year":"2018","journal-title":"Saudi Med J"},{"key":"10.1016\/j.ajog.2024.10.004_bib121","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00404-018-4803-8","article-title":"The diagnosis of PCOS in young infertile women according to different diagnostic criteria: the role of serum anti-M\u00fcllerian hormone","volume":"298","author":"Casadei","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2024.10.004_bib122","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1038\/s41598-018-22176-1","article-title":"Salivary and serum androgens with anti-M\u00fcllerian hormone measurement for the diagnosis of polycystic ovary syndrome","volume":"8","author":"Sathyapalan","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajog.2024.10.004_bib123","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jpag.2018.02.126","article-title":"The diagnostic value of anti-Mullerian hormone in early post menarche adolescent girls with polycystic ovarian syndrome","volume":"31","author":"Kocaay","year":"2018","journal-title":"J\u00a0Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.ajog.2024.10.004_bib124","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.mefs.2018.05.009","article-title":"A\u00a0negative correlation of thyroid stimulating hormone with anti_mullerian hormone and with luteinizing hormone in polycystic ovary syndrome and\/or hypothyroid women","volume":"23","author":"Al-jaff","year":"2018","journal-title":"Middle East Fertil Soc J"},{"key":"10.1016\/j.ajog.2024.10.004_bib125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203129","article-title":"Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women","volume":"13","author":"Yue","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2024.10.004_bib126","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3904\/kjim.2016.038","article-title":"Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-M\u00fcllerian hormone cutoff value","volume":"32","author":"Song","year":"2017","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.ajog.2024.10.004_bib127","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/cen.13269","article-title":"Anti-M\u00fcllerian hormone reflects the severity of polycystic ovary syndrome","volume":"86","author":"Jacob","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ajog.2024.10.004_bib128","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.fertnstert.2017.11.012","article-title":"Differential rate in decline in ovarian reserve markers in women with polycystic ovary syndrome compared with control subjects: results of a longitudinal study","volume":"109","author":"Ahmad","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2024.10.004_bib129","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/cen.13415","article-title":"Age-stratified thresholds of anti-M\u00fcllerian hormone improve prediction of polycystic ovary syndrome over a population-based threshold","volume":"87","author":"Quinn","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ajog.2024.10.004_bib130","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1507\/endocrj.EJ16-0501","article-title":"Relationship between serum anti-Mullerian hormone and clinical parameters in polycystic ovary syndrome","volume":"64","author":"Matsuzaki","year":"2017","journal-title":"Endocr J"},{"key":"10.1016\/j.ajog.2024.10.004_bib131","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000481532","article-title":"New diagnostic criteria of polycystic ovarian morphology for adolescents: impact on prevalence and hormonal profile","volume":"88","author":"Merino","year":"2017","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.ajog.2024.10.004_bib132","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ygcen.2017.12.007","article-title":"Evaluation of different ranges of LH : FSH ratios in polycystic ovarian syndrome PCOS) \u2013 clinical based case control study Post-Graduate and Research Department of Zoology, St. Thomas College Kozhencherry","volume":"260","author":"Malini","year":"2018","journal-title":"Gen Comp Endocrinol"},{"key":"10.1016\/j.ajog.2024.10.004_bib133","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1210\/js.2017-00192","article-title":"Insulin Resistance, Hyperinsulinemia, and Mitochondria Dysfunction in Nonobese Girls With Polycystic Ovarian Syndrome","volume":"1","author":"Cree-Green","year":"2017","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.ajog.2024.10.004_bib134","doi-asserted-by":"crossref","first-page":"380","DOI":"10.5935\/0034-7280.20160076","article-title":"Tear osmolarity and tear function assessment in patients with polycystic ovary syndrome","volume":"75","author":"Guliyev","year":"2016","journal-title":"Rev Bras Oftalmol"},{"key":"10.1016\/j.ajog.2024.10.004_bib135","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1515\/jpem-2015-0461","article-title":"17-hydroxyprogesterone responses to human chorionic gonadotropin are not associated with serum anti-Mullerian hormone levels among adolescent girls with polycystic ovary syndrome","volume":"29","author":"Hou","year":"2016","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.ajog.2024.10.004_bib136","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4274\/jcrpe.3253","article-title":"Anti-M\u00fcllerian hormone and inhibin-A, but not inhibin-B or insulin-like Peptide-3, may be used as surrogates in the diagnosis of polycystic ovary syndrome in adolescents: preliminary results","volume":"8","author":"Yetim","year":"2016","journal-title":"J\u00a0Clin Res Pediatr Endocrinol"},{"key":"10.1016\/j.ajog.2024.10.004_bib137","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1159\/000446111","article-title":"Do the anti-M\u00fcllerian hormone levels of adolescents with polycystic ovary syndrome, those who are at risk for developing polycystic ovary syndrome, and those who exhibit isolated oligomenorrhea differ from those of adolescents with normal menstrual cycles?","volume":"85","author":"Savas-Erdeve","year":"2016","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.ajog.2024.10.004_bib138","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00404-015-3889-5","article-title":"Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria","volume":"293","author":"Jamil","year":"2016","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2024.10.004_bib139","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1590\/2359-3997000000215","article-title":"Age related endocrine patterns observed in polycystic ovary syndrome patients vs. ovulatory controls: descriptive data from a university based infertility center","volume":"60","author":"Rashidi","year":"2016","journal-title":"Arch Endocrinol Metab"},{"key":"10.1016\/j.ajog.2024.10.004_bib140","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10815-015-0641-9","article-title":"Anti-M\u00fcllerian hormone gene polymorphism is associated with androgen levels in Chinese polycystic ovary syndrome patients with insulin resistance","volume":"33","author":"Zheng","year":"2016","journal-title":"J\u00a0Assist Reprod Genet"},{"key":"10.1016\/j.ajog.2024.10.004_bib141","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1080\/09513590.2016.1193140","article-title":"Association between anti-Mullerian hormone and insulin resistance in non-obese adolescent females with polycystic ovary syndrome","volume":"32","author":"Tokmak","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2024.10.004_bib142","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4158\/EP15903.OR","article-title":"AMH measurement versus ovarian ultrasound in the diagnosis of polycystic ovary syndrome in different phenotypes","volume":"22","author":"Carmina","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ajog.2024.10.004_bib143","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.fertnstert.2015.12.023","article-title":"Comparative assessment of fi ve serum antim \u20ac ullerian hormone assays for the diagnosis of polycystic ovary syndrome","volume":"105","author":"Pigny","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2024.10.004_bib144","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3109\/09513590.2016.1161019","article-title":"Role of kisspeptin in polycystic ovary syndrome (PCOS)","volume":"32","author":"Emekci Ozay","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2024.10.004_bib145","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/ajo.12366","article-title":"Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan","volume":"55","author":"Tremellen","year":"2015","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2024.10.004_bib146","first-page":"227","article-title":"Anti-Mullerian hormon level and polycystic ovarian syndrome diagnosis","volume":"13","author":"Zadehmodarres","year":"2015","journal-title":"Iran J Reprod Med"},{"key":"10.1016\/j.ajog.2024.10.004_bib147","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3109\/09513590.2015.1025380","article-title":"Hirsutism and oligomenorrhea are appropriate screening criteria for polycystic ovary syndrome in adolescents","volume":"31","author":"Villarroel","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2024.10.004_bib148","doi-asserted-by":"crossref","first-page":"989","DOI":"10.14740\/jocmr2375w","article-title":"Serum copeptin, PENTRAXIN 3, anti-Mullerian hormone levels with echocardiography and carotid artery intima-media thickness in adolescents with polycystic ovary syndrome","volume":"7","author":"Deveer","year":"2015","journal-title":"J\u00a0Clin Med Res"},{"key":"10.1016\/j.ajog.2024.10.004_bib149","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4274\/tjod.21549","article-title":"Is anti\u2013Mullerian hormone a good diagnostic marker for adolescent and young adult patients with polycystic ovary syndrome?","volume":"12","author":"Tokmak","year":"2015","journal-title":"Turk J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.10.004_bib150","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10815-013-0149-0","article-title":"Diagnosis of polycystic ovary syndrome: AMH in combination with clinical symptoms","volume":"31","author":"Sahmay","year":"2014","journal-title":"J\u00a0Assist Reprod Genet"},{"key":"10.1016\/j.ajog.2024.10.004_bib151","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s10815-014-0300-6","article-title":"Anti-Mullerian hormone as a diagnostic and prognostic tool for PCOS patients","volume":"31","author":"Wiweko","year":"2014","journal-title":"J\u00a0Assist Reprod Genet"},{"key":"10.1016\/j.ajog.2024.10.004_bib152","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejogrb.2014.06.018","article-title":"Comparison of serum anti-M\u00fcllerian hormone levels in normal weight and overweight\u2013obese adolescent patients with polycystic ovary syndrome","volume":"180","author":"Cengiz","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2024.10.004_bib153","first-page":"1175","article-title":"Anti-Mullerian hormone may be a useful adjunct in the diagnosis of polycystic ovary syndrome in nonobese adolescents","volume":"27","author":"Sopher","year":"2014","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.ajog.2024.10.004_bib154","doi-asserted-by":"crossref","first-page":"E2539","DOI":"10.1210\/jc.2014-1180","article-title":"Circulating irisin and glucose-dependent insulinotropic peptide are associated with the development of polycystic ovary syndrome","volume":"99","author":"Chang","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2024.10.004_bib155","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/humrep\/det469","article-title":"The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-M\u00fcllerian hormone","volume":"29","author":"Lauritsen","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2024.10.004_bib156","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00404-014-3317-2","article-title":"Anti-Mullerian hormone: an indicator for the severity of polycystic ovarian syndrome","volume":"290","author":"K\u00f6ninger","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2024.10.004_bib157","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3109\/09513590.2013.777415","article-title":"The role of serum anti-M\u00fcllerian hormone (AMH) in the hormonal diagnosis of polycystic ovary syndrome","volume":"29","author":"Casadei","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2024.10.004_bib158","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/humrep\/det015","article-title":"The relationship of serum anti- Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study","volume":"28","author":"Homburg","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2024.10.004_bib159","first-page":"1866","article-title":"Anti Mullerian hormone: a potential marker for recruited Non growing follicle of ovarian pool in women with polycystic ovarian syndrome","volume":"7","author":"Saikumar","year":"2013","journal-title":"J\u00a0Clin Diagn Res"},{"key":"10.1016\/j.ajog.2024.10.004_bib160","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/aogs.12247","article-title":"Elevated serum levels of anti-M\u00fcllerian hormone can be \u0131ntroduced as a new diagnostic marker for polycystic ovary syndrome","volume":"92","author":"Sahmay","year":"2013","journal-title":"Acta Obstet Gynecol Scand Published online"},{"key":"10.1016\/j.ajog.2024.10.004_bib161","doi-asserted-by":"crossref","first-page":"E1866","DOI":"10.1210\/jc.2013-2458","article-title":"Increased frequency of the anti-M\u00fcllerian-inhibiting hormone Receptor 2 (AMHR2) 482 A>G polymorphism in women with polycystic ovary syndrome: relationship to luteinizing hormone levels","volume":"98","author":"Georgopoulos","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2024.10.004_bib162","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3109\/09513590.2012.736563","article-title":"Effects of metformin on serum insulin and anti-M\u00fcllerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome","volume":"29","author":"Nascimento","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2024.10.004_bib163","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jcma.2011.12.007","article-title":"Anti-Mullerian hormone serum level as a predictive marker of ovarian function in Taiwanese women","volume":"75","author":"Chao","year":"2012","journal-title":"J\u00a0Chin Med Assoc"},{"key":"10.1016\/j.ajog.2024.10.004_bib164","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1507\/endocrj.EJ12-0055","article-title":"Differences of the association of anti-M\u00fcllerian hormone with clinical or biochemical characteristics between women with and without polycystic ovary syndrome","volume":"59","author":"Woo","year":"2012","journal-title":"Endocr J"},{"key":"10.1016\/j.ajog.2024.10.004_bib165","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1515\/jpem-2012-0013","article-title":"Elevated serum anti-M\u00fcllerian hormone in adolescents with polycystic ovary syndrome: relationship to ultrasound features","volume":"25","author":"Pawelczak","year":"2012","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.ajog.2024.10.004_bib166","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1093\/humrep\/des213","article-title":"Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?","volume":"27","author":"Eilertsen","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2024.10.004_bib167","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/uog.11202","article-title":"Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome?","volume":"40","author":"Catteau-Jonard","year":"2012","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.10.004_bib168","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.fertnstert.2011.04.003","article-title":"Antim \u20ac ullerian hormone and polycystic ovary syndrome","volume":"96","author":"Lin","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2024.10.004_bib169","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1055\/s-0031-1286307","article-title":"Anti-M\u00fcllerian hormone in women with polycystic ovary syndrome before and after therapy with metformin","volume":"43","author":"Tomova","year":"2011","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.ajog.2024.10.004_bib170","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1093\/humrep\/der297","article-title":"Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries","volume":"26","author":"Dewailly","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2024.10.004_bib171","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ejogrb.2011.06.006","article-title":"Is the plasma anti-M\u00fcllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?","volume":"158","author":"Ska\u0142ba","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2024.10.004_bib172","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.fertnstert.2011.06.016","article-title":"Evaluation of serum antiMullerian hormone and inhibin B concentrations in the differential diagnosis of secondary oligoamenorrhea","volume":"96","author":"Li","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2024.10.004_bib173","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00508-010-1426-x","article-title":"Elevated serum anti-Mullerian hormone in adolescent and young adult Chinese patients with polycystic ovary syndrome","volume":"122","author":"Li","year":"2010","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.ajog.2024.10.004_bib174","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.fertnstert.2009.11.002","article-title":"Serum antiMullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS)","volume":"94","author":"Hart","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2024.10.004_bib175","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.mefs.2010.08.005","article-title":"Anti- M\u00fcllerian hormone in polycystic ovary syndrome and normo-ovulatory women: correlation with clinical, hormonal and ultrasonographic parameters","volume":"15","author":"Begawy","year":"2010","journal-title":"Middle East Fertil Soc J"},{"key":"10.1016\/j.ajog.2024.10.004_bib176","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1210\/jc.2009-2106","article-title":"Serum anti-Mullerian hormone concentrations are elevated in oligomenorrheic girls without evidence of hyperandrogenism","volume":"95","author":"Park","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2024.10.004_bib177","doi-asserted-by":"crossref","first-page":"E238","DOI":"10.1152\/ajpendo.90684.2008","article-title":"Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels","volume":"296","author":"Piouka","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.ajog.2024.10.004_bib178","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/humrep\/den482","article-title":"Long-term follow-up of patients with polycystic ovary syndrome: reproductive outcome and ovarian reserve","volume":"24","author":"Hudecova","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2024.10.004_bib179","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1365-2265.2009.03604.x","article-title":"Adiponectin levels in adolescent girls with polycystic ovary syndrome (PCOS)","volume":"71","author":"Pinhas-hamiel","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ajog.2024.10.004_bib180","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1210\/jc.2007-2205","article-title":"A\u00a0functional anti-Mullerian hormone gene polymorphism is associated with follicle number and androgen levels in polycystic ovary syndrome patients","volume":"93","author":"Kevenaar","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2024.10.004_bib181","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1210\/jc.2007-0267","article-title":"Anti-Mullerian hormone levels in peripubertal daughters of women with polycystic ovary syndrome","volume":"92","author":"Crisosto","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2024.10.004_bib182","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejogrb.2007.01.012","article-title":"Anti-M\u00fcllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome","volume":"134","author":"Somunkiran","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2024.10.004_bib183","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1210\/jc.2005-2076","article-title":"Serum Anti-M\u00fcllerian Hormone as a Surrogate for Antral Follicle Count for Definition of the polycystic ovary syndrome","volume":"91","author":"Pigny","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2024.10.004_bib184","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1093\/humrep\/deh850","article-title":"Serum anti-M\u00fcllerian hormone levels remain high until Serum anti-Mu late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome","volume":"20","author":"Piltonen","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2024.10.004_bib185","first-page":"232","article-title":"Anti-M\u00fcllerian hormone: plasma levels in women with polycystic ovary syndrome and with premature ovarian failure","volume":"10","author":"Ska\u0142ba","year":"2011","journal-title":"Menopause Rev Menopauzalny"},{"key":"10.1016\/j.ajog.2024.10.004_bib186","doi-asserted-by":"crossref","DOI":"10.1080\/09513590.2023.2247098","article-title":"The role of anti-Mullerian hormone and other correlates in patients with polycystic ovary syndrome","volume":"39","author":"Moursi","year":"2023","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2024.10.004_bib187","doi-asserted-by":"crossref","first-page":"3","DOI":"10.69861\/marmcj.2024.v17.i1.02","article-title":"The Evaluation of Anti-Mullerian Hormone (AMH) in Early Diagnosis of Polycystic Ovarian Syndrome (PCOS)","volume":"17","author":"Jannat","year":"2024","journal-title":"MARMCJ"},{"key":"10.1016\/j.ajog.2024.10.004_bib188","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4103\/MJBL.MJBL_523_23","article-title":"The association between melatonin hormone and reproductive hormones in polycystic ovary syndrome: a case-control study","volume":"21","author":"Edan","year":"2024","journal-title":"Med J Babylon"},{"key":"10.1016\/j.ajog.2024.10.004_bib189","first-page":"410","article-title":"The anti-M\u00fcllerian hormone: a useful tool for diagnosis of polycystic ovary syndrome","volume":"81","author":"Chaabouni","year":"2023","journal-title":"Ann Biol Clin (Paris)"},{"key":"10.1016\/j.ajog.2024.10.004_bib190","doi-asserted-by":"crossref","first-page":"21","DOI":"10.21608\/zjps.2024.263254.1060","article-title":"The adjunct role of anti Mullerian hormone (AMH) in diagnosing polycystic ovary syndrome","volume":"33","author":"Alsolaiman","year":"2024","journal-title":"Zagazig J Pharm Sci"},{"key":"10.1016\/j.ajog.2024.10.004_bib191","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/cen.14851","article-title":"Serum GDF9 and BMP15 as potential markers of ovarian function in women with and without polycystic ovary syndrome","volume":"98","author":"Riepsamen","year":"2023","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ajog.2024.10.004_bib192","doi-asserted-by":"crossref","first-page":"397","DOI":"10.4103\/ijmr.IJMR_4608_20","article-title":"Serum anti-M\u00fcllerian hormone: a potential biomarker for polycystic ovary syndrome","volume":"158","author":"Halder","year":"2023","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.ajog.2024.10.004_bib193","doi-asserted-by":"crossref","first-page":"612","DOI":"10.53350\/pjmhs22165612","article-title":"Relationship of anti-Mullerian hormone in polycystic ovary syndrome patients with different subgroups","volume":"16","author":"Farooq","year":"2022","journal-title":"Pak J Med Heal Sci"},{"key":"10.1016\/j.ajog.2024.10.004_bib194","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/cen.12557","article-title":"Polycystic ovary syndrome and anti-M\u00fcllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins","volume":"81","author":"Cassar","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ajog.2024.10.004_bib195","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/humrep\/dex226","article-title":"Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-M\u00fcllerian hormone using cluster analysis","volume":"32","author":"Lie Fong","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2024.10.004_bib196","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s12020-023-03404-9","article-title":"Plasma-free metanephrines, nerve growth factor, and renalase significance in patients with PCOS","volume":"81","author":"Robeva","year":"2023","journal-title":"Endocrine"},{"key":"10.1016\/j.ajog.2024.10.004_bib197","doi-asserted-by":"crossref","DOI":"10.1080\/09513590.2024.2312895","article-title":"Metabolic disparities between obese and non-obese patients with polycystic ovary syndrome: implications for endometrial receptivity indicators","volume":"40","author":"Li","year":"2024","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2024.10.004_bib198","doi-asserted-by":"crossref","DOI":"10.1111\/cob.12638","article-title":"Increased body mass index is negatively associated with ovarian reserve as measured by anti-M\u00fcllerian hormone in patients with polycystic ovarian syndrome","volume":"14","author":"Kloos","year":"2024","journal-title":"Clin Obes"},{"key":"10.1016\/j.ajog.2024.10.004_bib199","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1093\/humrep\/dead081","article-title":"Factors affecting the distribution of serum anti-M\u00fcllerian hormone levels among infertile Asian women: a multi-nation, multi-centre, and multi-ethnicity prospective cohort study","volume":"38","author":"Tzeng","year":"2023","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2024.10.004_bib200","first-page":"103","article-title":"Exploring the link between serum vitamin D and anti-M\u00fcllerian hormone in polycystic ovary syndrome among reproductive-age women","volume":"10","author":"Arumalla","year":"2024","journal-title":"J\u00a0Res Appl Basic Med Sci"},{"key":"10.1016\/j.ajog.2024.10.004_bib201","article-title":"Exploring serum vitamin D, sex hormones, and lipid profile disparities in women with and without polycystic ovarian syndrome: a case-control study","volume":"16","author":"Akinola","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.ajog.2024.10.004_bib202","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.fertnstert.2017.08.012","article-title":"Efficacy of predictive models for polycystic ovary syndrome using serum levels of two antiM\u00fcllerian hormone isoforms (proAMH and AMHN,C)","volume":"108","author":"Pankhurst","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2024.10.004_bib203","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.51248\/.v43i4.2312","article-title":"Diagnostic utility of serum anti-Mullerian hormone levels in south Indian women with polycystic ovarian syndrome","volume":"43","author":"Narayanaswamy","year":"2023","journal-title":"Biomedicine"},{"key":"10.1016\/j.ajog.2024.10.004_bib204","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1111\/jog.15972","article-title":"Cut-off value for anti-M\u00fcllerian hormone in the diagnostic criteria for polycystic ovary syndrome in the Japanese population","volume":"50","author":"Noguchi","year":"2024","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.ajog.2024.10.004_bib205","first-page":"422","article-title":"Cord blood anti-M\u00fcllerian hormone levels are higher in female newborns from women with polycystic ovary syndrome (PCOS) when compared to non-PCOS controls, irrespective of body mass index; a prospective case-control study","volume":"27","author":"Baydemir","year":"2023","journal-title":"J\u00a0Bras Reprod Assist"},{"key":"10.1016\/j.ajog.2024.10.004_bib206","first-page":"98","article-title":"Comparative evaluation of diagnostic efficacy of serum anti-M\u00fcllerian hormone and ultrasound in polycystic ovarian syndrome","volume":"10","author":"Kumari","year":"2018","journal-title":"J\u00a0S Asian Fed Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.10.004_bib207","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/humrep\/dead050","article-title":"Changes in circulating forms of anti-Mu\u00fcllerian hormone and androgens in women with and without PCOS: a systematic longitudinal study throughout pregnancy","volume":"38","author":"Peign\u00e9","year":"2023","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2024.10.004_bib208","first-page":"261","article-title":"Cardiometabolic risk factors and its association with hyperandrogenemia among Sudanese reproductive women with polycystic ovary syndrome","volume":"13","author":"Elmugadam","year":"2023","journal-title":"Int J Biomed"},{"key":"10.1016\/j.ajog.2024.10.004_bib209","first-page":"3115","article-title":"Assessment of anti M\u00fcllerian hormone among women with polycystic ovarian syndrome in Khartoum State","volume":"7","author":"Ali","year":"2024","journal-title":"Jour Med Resh Heal Sci"},{"key":"10.1016\/j.ajog.2024.10.004_bib210","first-page":"78","article-title":"Assessing the clinical diagnostic value of anti-M\u00fcllerian hormone in polycystic ovarian syndrome and its correlation with clinical and metabolism indicators","volume":"17","author":"Wang","year":"2024","journal-title":"J\u00a0Ovarian Res"},{"key":"10.1016\/j.ajog.2024.10.004_bib211","doi-asserted-by":"crossref","first-page":"8","DOI":"10.69656\/pjp.v20i1.1598","article-title":"Anti-M\u00fcllerian hormone: a better bio marker for assessment of anovulation in polycystic ovarian syndrome compared to conventional biomarkers","volume":"20","author":"Goheer","year":"2024","journal-title":"Pak J Phsyiol"},{"key":"10.1016\/j.ajog.2024.10.004_bib212","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cgh.2023.08.020","article-title":"AntiMullerian hormone, a marker of ovarian reserve, is protective against presence and severity of NASH in premenopausal women","volume":"22","author":"Maldonado","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ajog.2024.10.004_bib213","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jadohealth.2016.10.015","article-title":"Anti-M\u00fcllerian hormone in obese adolescent girls with polycystic ovary syndrome","volume":"60","author":"Kim","year":"2017","journal-title":"J\u00a0Adolesc Health"},{"key":"10.1016\/j.ajog.2024.10.004_bib214","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.rbmo.2019.04.002","article-title":"Anti-M\u00fcllerian hormone as a diagnostic tool for PCOS under different diagnostic criteria in an unselected population","volume":"39","author":"Bozdag","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ajog.2024.10.004_bib215","doi-asserted-by":"crossref","first-page":"376","DOI":"10.38053\/acmj.1323489","article-title":"Anti-M\u00fcllerian hormone and HOMA-IR in different phenotypes of polycystic ovary syndrome on insulin resistance","volume":"5","author":"\u00d6nal","year":"2023","journal-title":"Anatol Curr Med J"},{"key":"10.1016\/j.ajog.2024.10.004_bib216","doi-asserted-by":"crossref","first-page":"188","DOI":"10.51253\/pafmj.v74i1.9166","article-title":"Anti-Mullarian hormone as A diagnostic marker of polycystic ovary syndrome","volume":"74","author":"Abbas","year":"2024","journal-title":"Pak Armed Forces Med J"},{"key":"10.1016\/j.ajog.2024.10.004_bib217","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1515\/hmbci-2021-0078","article-title":"Anti Mullerian hormone as a diagnostic tool for polycystic ovary syndrome in women of reproductive age with morbid obesity","volume":"43","author":"Oueslati","year":"2022","journal-title":"Horm Mol Biol Clin Investig"},{"key":"10.1016\/j.ajog.2024.10.004_bib218","first-page":"311","article-title":"Analysis of new biomarkers for the diagnosis of polycystic ovary syndrome in adolescents","volume":"19","author":"Tun\u00e7","year":"2021","journal-title":"Guncel Pediatr"},{"key":"10.1016\/j.ajog.2024.10.004_bib219","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1408879","article-title":"Anti-M\u00fcllerian hormone a surrogate of follicular fluid oxidative stress in polycystic ovary syndrome?","volume":"12","author":"Vale-Fernandes","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.ajog.2024.10.004_bib220","doi-asserted-by":"crossref","first-page":"36","DOI":"10.32771\/inajog.v12i1.2031","article-title":"Body composition parameters, adiponectin, leptin and adiponectin\/leptin ratio are correlated with LH\/FSH ratio in women with PCOS but not in women without PCOS","volume":"12","author":"Pratama","year":"2024","journal-title":"Indones J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.10.004_bib221","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s10815-012-9839-2","article-title":"Different diagnostic power of anti-Mullerian hormone in evaluating women with polycystic ovaries with and without hyperandrogenism","volume":"29","author":"Li","year":"2012","journal-title":"J\u00a0Assist Reprod Genet"},{"key":"10.1016\/j.ajog.2024.10.004_bib222","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1369248","article-title":"The association between leptin, adiponectin levels and the ovarian reserve in women of reproductive age","volume":"15","author":"Nikolettos","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ajog.2024.10.004_bib223","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3923\/pjbs.2023.241.248","article-title":"The association of anti-Mullerian hormone and infertility hormonal imbalance with polycystic ovarian syndrome among Iraqi patients","volume":"26","author":"Taha","year":"2023","journal-title":"Pak J Biol Sci"},{"key":"10.1016\/j.ajog.2024.10.004_bib224","first-page":"32","article-title":"The relation between serum anti-Mullerian hormone levels and follicle count in polycystic ovary syndrome","volume":"4","author":"Tanr\u0131dan Okcu","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ajog.2024.10.004_bib225","doi-asserted-by":"crossref","first-page":"89","DOI":"10.31083\/j.ceog5004089","article-title":"The reliability of serum Neuregulin-4 as a marker of polycystic ovarian syndrome with respect to adiposity parameters","volume":"50","author":"Nori","year":"2023","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.10.004_bib226","first-page":"34","article-title":"The role of the AMH, SHBG and LH\/FSH ratio in the diagnosis of polycystic ovary syndrome in adolescent","volume":"18","author":"B\u00fcy\u00fckyilmaz","year":"2024","journal-title":"Turk J Pediatr Dis"},{"key":"10.1016\/j.ajog.2024.10.004_bib227","doi-asserted-by":"crossref","first-page":"158","DOI":"10.54153\/sjpas.2024.v6i2.693","article-title":"Un association of anti-Mullerian hormone gene (rs4807216) polymorphism in polycystic ovary syndrome (PCOS) among Iraqi Women","volume":"6","author":"Mohammad Mustafa","year":"2024","journal-title":"Samarra J Pure Appl Sci"},{"key":"10.1016\/j.ajog.2024.10.004_bib228","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1507\/endocrj.EJ22-0081","article-title":"Anti-M\u00fcllerian hormone levels in the diagnosis of adolescent polycystic ovarian syndrome: a systematic review and meta-analysis","volume":"69","author":"Tsukui","year":"2022","journal-title":"Endocr J"},{"key":"10.1016\/j.ajog.2024.10.004_bib229","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijpam.2017.09.002","article-title":"Polycystic ovary syndrome: pelvic MRI as alternative to pelvic ultrasound for the diagnosis in overweight and obese adolescent girls","volume":"4","author":"Kayemba-Kay\u2019s","year":"2017","journal-title":"Int J Pediatr Adolesc Med"},{"key":"10.1016\/j.ajog.2024.10.004_bib230","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/jmri.23992","article-title":"Ovarian imaging by magnetic resonance in adolescent girls with polycystic ovary syndrome and age-matched controls","volume":"38","author":"Brown","year":"2013","journal-title":"J\u00a0Magn Reson Imaging"},{"key":"10.1016\/j.ajog.2024.10.004_bib231","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.fertnstert.2005.04.039","article-title":"Ovarian imaging by magnetic resonance in obese adolescent girls with polycystic ovary syndrome: a pilot study","volume":"84","author":"Yoo","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2024.10.004_bib232","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1210\/jc.2013-1393","article-title":"Can anti-M\u00fcllerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data","volume":"98","author":"Iliodromiti","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2024.10.004_bib233","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1210\/jc.2012-1440","article-title":"Serum anti-M\u00fcllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood","volume":"97","author":"Lie Fong","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937824010524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937824010524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T18:53:05Z","timestamp":1737399185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937824010524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":232,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0002937824010524"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2024.10.004","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New insights into the relationship of antim\u00fcllerian hormone with polycystic ovary syndrome and its diagnostic accuracy: an updated and extended meta-analysis using a marginal beta-binomial model","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2024.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}